PlainRecalls

G & W Laboratories Inc

Compiled from official public sources by the publisher.

6 recalls on record · Latest: Feb 14, 2018

Subscribe to new G & W Laboratories Inc recalls (RSS)

Agency notice ledger

Federal filing book G & W Laboratories Inc LIGHT-BOOK · SINGLE-AGENCY

#2,157 of 14,151 · 6 notices · 0.006% archive

  • BOOK 6 notices
  • RANK #2,157 of 14,151
  • SHARE 0.006% archive
  • AGENCY FDA Drug (6)
  • CAT drugs
  • CATS 2 categories
  • LATEST Feb 14, 2018
  • PHOTO 1908 Brands

Nearest notice-volume peer: 1908 Brands (0 notice gap)

G & W Laboratories Inc accounts for about 0.006% of the 104,423-notice archive on 6 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How G & W Laboratories Inc compares to 14,151 recalling firms

G & W Laboratories Inc ranks 2,157th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

G & W Laboratories Inc vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

6 2157th of 14151 higher than 11,804 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

G & W Laboratories Inc in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows G & W Laboratories Inc holds about 0.006% of archive notices alongside 6 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Feb 14, 2018

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.
FDA Drug Low Jul 12, 2017

G & W Clobetasol Propionate Ointment 0.05%, packaged in a) 15 g tube (NDC 0713-0656-15), b) 30 g tube (NDC 0713-0656-31, c) 45 g tube (NDC 0713-0656-37), d) 60 g tube (NDC 0713-0656-60), Rx Only, Manufactured by G & W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080
FDA Drug Low Apr 12, 2017

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), and c) 90 g tubes (NDC 0713-0638-18), Rx only, Manufactured by: G&W Laboratories, Inc., South Plainfeld, NJ 07080.
FDA Drug Low Mar 22, 2017

Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL applicator bottles (NDC 0472-0987-92), Rx Only, Manufactured by: G&W Laboratories, Inc., 111 Coolidge Street, South Plainfield, NJ 07080; Distributed by: Actavis Mid Atlantic LLC, 1877 Kawai Road, Lincolnton, NC 28092.
FDA Drug Moderate Mar 8, 2017

Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30, Rx only, Manufactured by: G&W Laboratories Inc. South Plainfield, NJ 07080, Distributed by Iroko Pharmaceuticals, LLC Philadelphia, PA 19112, NDC 42211-0102-43
FDA Drug Low Jan 8, 2014

G & W Fluocinolone Acetonide Cream USP 0.025%, a) 15 gm (NDC 0713-0222-15), b) 60 gm (NDC 0713-0222-60 ), Rx Only, Manufactured by: G&W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080

G & W Laboratories Inc holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (6 here).

1908 Brands 6 Abbott Molecular 6 Accriva Diagnostics, Inc. 6 Advance Medical Designs, Inc. 6 Agave Dream 6

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Aire-Master of America Inc 6 Apollo Care 6 Aspen Biopharma Labs Pvt., Ltd. 6 Ben Venue Laboratories Inc 6

Frequently Asked Questions

How many federal recall notices name G & W Laboratories Inc? ▼
PlainRecalls indexes 6 distinct federal recall events naming G & W Laboratories Inc, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does G & W Laboratories Inc sit among other recalling firms? ▼
G & W Laboratories Inc ranks #2,157 of 14,151 by distinct recall-event count among 14,151 firms in this archive (83rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of G & W Laboratories Inc's notices? ▼
FDA Drug accounts for 6 of this firm's 6 indexed notices.
What product category dominates G & W Laboratories Inc's filing book? ▼
Filings for G & W Laboratories Inc span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
G & W Laboratories Inc: 6 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming G & W Laboratories Inc; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026